Trials / Completed
CompletedNCT05422976
EVI-01-IT Safety Study
Safety and Tolerability of a Single Intra-articular Highly Concentrated Hyaluronic Acid Injection in the Treatment of Symptomatic Knee Osteoarthritis : Pilot, 6-months, Open-label, Single-arm Investigation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Aptissen SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, single arm, pilot study to assess the safety and tolerability of a single intra-articular injection of EVI-01 for the treatment of symptomatic knee osteoarthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EVI-01 | High molecular weight Hyaluronic Acid |
Timeline
- Start date
- 2022-06-23
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2022-06-21
- Last updated
- 2023-07-21
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05422976. Inclusion in this directory is not an endorsement.